These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29733229)
41. Adnexotropic and granulomatous mycosis fungoides following TNF-α inhibitor treatment. Doughty H; Scripture A; Carter JB; Sriharan A; Yan S; Lansigan F; Momtahen S J Cutan Pathol; 2023 Jul; 50(7):611-616. PubMed ID: 37127841 [TBL] [Abstract][Full Text] [Related]
42. Mycosis fungoides (CTCL) associated with colorectal adenocarcinoma. A rare case of combined response to neoadjuvant therapy. Grimaldi L; Danzi R; Sivero L; De Capua M; Coppola A; Peltrini R; Mascolo M; Danzi M; Corcione F Ann Ital Chir; 2021 Mar; 10():. PubMed ID: 33798118 [TBL] [Abstract][Full Text] [Related]
43. Mycosis fungoides with epidermal mucinosis: a variant of mycosis fungoides with a spongiosis-like pattern. Hu SW; Ratech H; Naeem R; Latkowski JA; Kamino H J Cutan Pathol; 2015 Oct; 42(10):730-8. PubMed ID: 26009972 [TBL] [Abstract][Full Text] [Related]
44. Acitretin for the treatment of cutaneous T-cell lymphoma. Cheeley J; Sahn RE; DeLong LK; Parker SR J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895 [TBL] [Abstract][Full Text] [Related]
45. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144 [TBL] [Abstract][Full Text] [Related]
46. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma. Qiu L; Liu F; Yi S; Li X; Liu X; Xiao C; Lian CG; Tu P; Wang Y J Invest Dermatol; 2018 Nov; 138(11):2388-2397. PubMed ID: 29803640 [TBL] [Abstract][Full Text] [Related]
47. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999 [TBL] [Abstract][Full Text] [Related]
48. Differential Response of Mycosis Fungoides Cells to Vorinostat. Bordeaux ZA; Reddy SV; Lee K; Lu W; Choi J; Miller M; Roberts C; Pollizzi A; Kwatra SG; Kwatra MM Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175780 [TBL] [Abstract][Full Text] [Related]
49. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Santucci M; Biggeri A; Feller AC; Burg G Arch Dermatol; 2000 Apr; 136(4):497-502. PubMed ID: 10768648 [TBL] [Abstract][Full Text] [Related]
50. Pruritus in cutaneous T-cell lymphoma: a review. Ahern K; Gilmore ES; Poligone B J Am Acad Dermatol; 2012 Oct; 67(4):760-8. PubMed ID: 22285672 [TBL] [Abstract][Full Text] [Related]
55. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review]. Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516 [TBL] [Abstract][Full Text] [Related]
56. Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma. Sokolowska-Wojdylo M; Florek A; Zaucha JM; Chmielowska E; Giza A; Knopinska-Posluszny W; Kulikowski W; Prejzner W; Romejko-Jarosinska J; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Rogowski W; Grzanka A; Placek W; Lugowska-Umer H; Kowalczyk A; Nowicki R; Jurczak W Am J Ther; 2016; 23(3):e749-56. PubMed ID: 24732904 [TBL] [Abstract][Full Text] [Related]
57. Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides. Foss F; Duvic M; Lerner A; Waksman J; Whittaker S Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):637-643. PubMed ID: 27637428 [TBL] [Abstract][Full Text] [Related]
58. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006 [TBL] [Abstract][Full Text] [Related]
59. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior. Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515 [TBL] [Abstract][Full Text] [Related]